XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 151 filers reported holding XENON PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 3.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $575,297 | +58.2% | 14,755 | +74.6% | 0.00% | – |
| Q1 2024 | $363,729 | -73.1% | 8,449 | -71.3% | 0.00% | – |
| Q4 2023 | $1,353,704 | +61.9% | 29,390 | +20.1% | 0.00% | – |
| Q3 2023 | $836,203 | +149.2% | 24,479 | +180.8% | 0.00% | – |
| Q2 2023 | $335,604 | +65.5% | 8,717 | +53.8% | 0.00% | – |
| Q1 2023 | $202,786 | -66.4% | 5,666 | -62.9% | 0.00% | – |
| Q4 2022 | $602,885 | -60.2% | 15,290 | -63.5% | 0.00% | -100.0% |
| Q3 2022 | $1,513,000 | +34.4% | 41,912 | +13.8% | 0.00% | – |
| Q1 2022 | $1,126,000 | – | 36,817 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,754,266 | $107,388,831 | 7.33% |
| Altium Capital Management LP | 360,600 | $14,059,794 | 5.74% |
| Affinity Asset Advisors, LLC | 994,227 | $38,764,911 | 4.47% |
| First Light Asset Management, LLC | 1,306,260 | $50,931,077 | 4.46% |
| Nan Fung Group Holdings Ltd | 106,680 | $4,159,453 | 4.44% |
| Ally Bridge Group (NY) LLC | 169,369 | $6,603,697 | 3.93% |
| TLS Advisors LLC | 32,956 | $1,285 | 3.22% |
| BRAIDWELL LP | 2,560,573 | $99,836,741 | 3.13% |
| Paradigm Biocapital Advisors LP | 2,043,280 | $79,667,487 | 3.05% |
| BRIDGER MANAGEMENT, LLC | 146,800 | $5,723,732 | 2.94% |